President, CEO of Cadence Pharmaceuticals Inc. (CADX, Financial) Theodore R Schroeder sells 50,000 shares of CADX on 10/01/2010 at an average price of $8.35 a share.
Cadence Pharmaceuticals Inc. has a market cap of $425.17 million; its shares were traded at around $8.41 .
Cadence Pharmaceuticals Inc. has a market cap of $425.17 million; its shares were traded at around $8.41 .
CEO Recent Trades:
- Sell: President, CEO Theodore R Schroeder sold 50,000 shares of CADX stock on 07/01/2010 at the average price of 6.99. Theodore R Schroeder owns at least 361,000 shares after this. The price of the stock has increased by 20.31% since.
Directors and Officers Recent Trades:
- Buy: Director Todd W Rich bought 10,000 shares of CADX stock on 05/11/2010 at the average price of 8.98. Todd W Rich owns at least 10,000 shares after this. The price of the stock has decreased by 6.35% since.
- Sell: EVP, CMO James B Breitmeyer sold 7,000 shares of CADX stock on 09/29/2010 at the average price of 8.5. James B Breitmeyer owns at least 10,000 shares after this. The price of the stock has decreased by 1.06% since.
- Sell: SVP David A Socks sold 10,000 shares of CADX stock on 06/14/2010 at the average price of 7.05. David A Socks owns at least 96,245 shares after this. The price of the stock has increased by 19.29% since.
- Sell: SVP David A Socks sold 10,000 shares of CADX stock on 05/10/2010 at the average price of 9.2. David A Socks owns at least 106,245 shares after this. The price of the stock has decreased by 8.59% since.
- Sell: EVP, CMO James B Breitmeyer sold 1,000 shares of CADX stock on 04/19/2010 at the average price of 10. James B Breitmeyer owns at least 10,000 shares after this. The price of the stock has decreased by 15.9% since.
